Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer By Washington Examiner May 19, 2014 6:46 am FacebookTwitterEmailPrint Add Washington Examiner on Google FacebookTwitterEmailPrint LONDON (AP) — Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer. Recommended Stories Carr says overseas call centers pose 'security issue' as part of FCC proposal listNational Symphony director joins Kennedy Center exodus following Trump movesFutures markets and crypto high on agenda of agency's new leader TagsMergers and AcquisitionsPfizerUnited Kingdom Related Content News Trump appoints Erika Kirk to Air Force Academy board position Education 9th Circuit upholds first grader’s free speech rights in ‘black lives matter’ drawing case Congressional Bennie Thompson easily wins Democratic primary for Mississippi House seat Congressional Harris and Fuller advance to runoff in Georgia special election to fill MTG’s House seat World At least six dead in Switzerland bus fire as police investigate possible ‘voluntary act’
